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Abstract   
 
The genome of Mycobacterium tuberculosis (Mtb) of latently infected individuals may 
hold the key to understanding the processes that lead to reactivation and progression to 
clinical disease. We report here analysis of pairs of Mtb isolates from putative prolonged 
latent TB cases. We identified two confirmed cases, and used whole genome sequencing 
to investigate the mutational processes that occur over decades in latent Mtb. We found 
an estimated mutation rate between 0.2 and 0.3 over 33 years, suggesting that latent 
Mtb accumulates mutations at rates similar to observations from cases of active disease. 
(Word-count: 93) 
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Introduction 
Failure to control tuberculosis (TB) is in part due to the ability of Mycobacterium 
tuberculosis (Mtb) to transition into a latent state, in which growth is curtailed by the 
host immune system and clinical signs of active disease are absent. People harboring 
latent Mtb have a 5–10% lifetime risk of contracting active TB (Dutta and Karakousis, 
2014). The infection outcome (i.e. latent infection versus active disease) seemingly 
depends on complex interactions between host and bacterial factors as well as the 
overall immune- and health status of the patient (Taarnhoj et al., 2011). It is estimated 
that one-third of the global human population is infected with latent Mtb, constituting a 
vast disease reservoir. As a genetically monomorphic organism(Boritsch et al., 2014; 
Eldholm and Balloux, 2016), the adaptational potential of Mtb, i.e. its capacity to 
genetically adapt to the host immune system or drug interventions, is tightly linked to 
its in vivo mutation rate (Eldholm and Balloux, 2016; Ford et al., 2013; Takiff and Feo, 
2015) and the type of accumulated mutations (synonymous vs non-synonymous). 
Despite this, dormancy remains an underreported aspect of Mtb biology, primarily due 
to limited availability of isolates collected both at the time of infection and at the onset 
of TB.  
Denmark possess a unique Mtb culture collection comprising isolates from all culture 
positive TB cases in Denmark, Greenland and the Faeroe Islands from the last 24 years 
(n=9,674) and a historical collection of Mtb isolates sampled during the 1960s (n=203). 
Using existing restriction fragment length typing (IS6110-RFLP) data, we have 
previously identified linked isolate-pairs separated by more than three decades, 
indicating cases of Mtb re-activation after prolonged latent infection (Lillebaek et al., 
2002). In one particularly striking case, two such isolates were sampled from within the 
same household (Lillebaek et al., 2002), a father and his son, diagnosed with pulmonary 
tuberculosis in 1961 and 1994, respectively. By subjecting this and other similarly 
linked isolate-pairs to whole-genome sequencing, we are therefore presented with a 
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rare and unique opportunity to shed more light on the mutational processes that occur 
over decades in latent Mtb. 
 
Methods 
 
Bacterial isolates. Historical isolates from the 1960s were originally stored as freeze-
dried samples until they were re-cultured in 2001. All isolates were stored in 15% 
glycerol at -80°C and were cultivated in Dubos media prior to growth on blood agar. 
Two to three colonies were picked for DNA extraction, which were performed according 
to the procedure used for RFLP fingerprinting (van Soolingen et al., 1991).  
 
Genome sequencing. All DNA samples were whole-genome sequenced on the Illumina 
HiSeq2000 platform as 2 x 100bp paired-end libraries with 500 bp inserts, with the 
exception of Mu879, which was sequenced on the Illumina MiSeq platform as a 2 x 150 
bp library (400 bp inserts) due to contamination of the initial DNA sample with 
Staphylococcus aureus. The sequence data described in this study is available from the 
European Nucleotide Archive (ENA) at this URL: 
http://www.ebi.ac.uk/ena/data/view/PRJEB10245. 
 
Read processing and variant calling. Illumina paired-end reads were pre-trimmed, 
using the program Trimmomatic to completely remove any residual TruSeq adapter 
fragments as well as leading and trailing nucleotides with Phred quality-scores below 3 
(Bolger et al., 2014). This was done to ensure optimal mapping conditions. Additionally, 
read-pairs in which one or both mates were shorter than 36bp or had an average base 
quality below 15 were discarded prior to mapping. Remaining reads were mapped to 
the Mtb H37Rv (GenBank Accession no.: AL123456) or the Mtb CTRI-2 (Accession no.: 
CP002992) genome sequences, using the Burrows-Wheeler Alignment tool (BWA 
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v0.7.10) (Li and Durbin, 2009). The Genome Analysis ToolKit (GATK) was used to 
accurately realign reads around long indels (DePristo et al., 2011). Median mapping 
depths ranged from 119-227 and average read lengths ranged from 96-150 bp (Table 
S1). In all 14 libraries >99% of reads mapped to the H37Rv reference genome, with 
>98% of its bases covered by at least one read. SAMtools v0.1.19 (Li et al., 2009) was 
used to call raw variants (using the mpileup and bcftools programs) from aligned reads 
with a minimum mapping quality (mapQ) of 30 to exclude reads mapping to multiple 
locations on the reference genome. Raw variants were then filtered so that only single 
nucleotide polymorphism (SNPs) covered by at least 5 reads and a minimum of one read 
in each direction. The minimum acceptable average mapQ of SNPs was set to 45. For the 
H37Rv reference genome only variants called as homozygous (0/0 or 1/1) in all samples 
by the bcftools variant caller were considered. For the CTRI-2 reference (Ilina et al., 
2013), variant calling was less stringent, so that all variants supported by 85% or more 
of the mapped reads in a sample were seen as fixated, while variants with lower 
coverage were kept as transitory mutations, but otherwise not considered in final 
analyses. With the CTRI-2 reference, the four samples (Mu837, Mu838, R94-2977 and 
R93-3208), mapped reads had error rates ≤0.15%. Individual coverage of fixed SNPs 
ranged from 35-213. To resolve large deletions and SNPs around Mtb repetitive regions, 
scaffolds were assembled using the SPAdes genome assembler version 3.5.0 
(http://bioinf.spbau.ru/spades) on quality-trimmed paired-end reads only. These were 
mapped onto the reference genome using the Geneious software’s ”Map to Reference” 
function (http://www.geneious.com). In resolving putative repetitive genes (such as pe-, 
ppe- or transposon genes) only regions in which repetitive elements were covered by 
scaffolds extending into non-repetitive regions by more than 1kbp were considered. 
Furthermore, all fixed SNPs called against the CTRI-2 reference were confirmed by 
visual inspection of mapped reads in Geneious. 
An in-house perl script was written to combine genome annotations and variants from 
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variant call format (vcf) files and to concatenate SNPs into alignments for phylogenetic 
analysis. Maximum likelihood phylogeny was calculated using PhyML (Guindon et al., 
2010) with the GTR substitution model (-I -Γ) and Maximum parsimony was calculated 
using MEGA (Tamura et al., 2013). Bootstrap values were calculated from 500 trees to 
confirm strong branch support (>95%) for all Mtb sublineages as well as the 
phylogenetic placement of primary-, secondary- and tertiary isolates. 
Variant effect analysis, IS-element mapping and dN/dS ratio estimates. The Protein 
Variation Effect Analyser (PROVEAN) software, which is a validated method for 
estimating the deleterious or neutral effects of individual amino acid variants (Choi et 
al., 2012), was used on intragenic SNPs. The program was run using default settings 
against the NCBI NR (non-redundant) protein database (version 2014-08-13). A 
Provean-score of -2.500, was used as an arbitrary threshold to distinguish between 
deleterious (below -2.5) and neutral (above -2.5) amino acid changes, which is slightly 
more conservative than the -2.182 used in the manuscript. The program IS-mapper 
(github.com/jhawkey/IS_mapper) was used to pin-point the location of insertions of the 
IS-element IS6110 along the CTRI-2 genome. The synonymous substitution rate per site 
(dS) to the non-synonymous substitution rate per site (dN) via the ratio ω = dN/dS was 
used as a global estimator of positive-, neutral- or purifying selection pressure.  These 
were calculated by using the number of non-synonymous (2,690,224) and synonymous 
(979,340) sites in all non-repetitive coding regions of the Mtb H37Rv genome. 
Corresponding P-values were calculated under the assumption that the numbers of non-
synonymous and synonymous mutations are independent Poisson random variables 
(Yang et al., 2011).  
 
Results & Discussion 
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Identification of true latent TB cases. To identify true cases of prolonged latent Mtb 
infection, a precise account of accumulated mutations occurring between infection and 
active disease is required. Re-activated isolates should harbor most if not all mutations 
observed in their putative origin, in addition to the mutations that have accumulated in 
the interim, and the primary isolate should ideally be placed as its most recent common 
ancestor (MRCA) on a phylogenetic tree. We therefore sequenced a total of 14 Mtb 
isolates from the two strain collections mentioned above. In total, 6 discrete isolate 
groups (Links 1-6), inferred from identical RFLP-profiles (Lillebaek et al., 2003), were 
evaluated. Each link comprised a primary “origin” isolate from the 1960s and a 
secondary (putatively re-activated) isolate from the 1990s. Additionally, Links 5 & 6 
included tertiary isolates that were likely recent transmissions of the respective 
secondary isolates (Figure 1a). Alignments of concatenated single nucleotide 
polymorphisms (SNPs) were used to determine the phylogeny of 14 isolates in relation 
to a global collection of sequenced reference Mtb isolates (Figure 1b; Table S2). Links 1 
& 2 were revealed to constitute a single monophyletic clade which, in addition to the 
previously described father and son isolates (Link 2; Mu838 and R94-3208), contained a 
primary isolate from the father’s niece (Link 1; Mu837), diagnosed with TB in 1961, and 
a secondary isolate from an unknown individual from the same geographic region of 
Denmark (link 1; R94-2977), who contracted the disease in 1994. Given that Mu837 was 
isolated from a one-year-old child it is highly unlikely, although not impossible, that the 
child was the direct source for R94-2977 (the recipient was five years at the time) as 
small children are generally not considered to be very contagious with TB. However, 
even if this child, the only available case with an identical RFLP profile to R94-2977, was 
not the direct source of transmission, the difference of only a single SNP between Mu837 
and the MRCA strongly indicates a close causal link between the two isolates. Therefore, 
it is very likely that transmission occurred within the same setting and within a 
relatively short time period (i.e. a few months) to both the one-year-old niece and the 
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latently infected individual. This is also supported by the complete lack of other isolates 
with the same typing profiles as R94-2977 in isolates collected since nationwide 
genotyping was introduced (in 1992) (Lillebaek et al., 2003), which is unlikely to have 
occurred in strains that were actively transmitted between 1961 and 1992. The 
difference of 5 SNPs and one IS6110-element (Table 1; Table S5) between Link 1 & 2 
MRCAs also makes the father’s isolate (Mu838) a highly unlikely transmission origin 
given that they were both diagnosed with TB in late 1961. 
None of the other putative linked isolates (Links 3-6) placed the primary isolate 
sufficiently close (<3 SNPs) to the MRCA of the secondary- and third isolates, to confirm 
re-activation. These cases therefore seem to be parts of broader and largely 
undocumented chains of transmission. In our view, however, this does not rule out the 
possibility that some of these secondary isolates underwent prolonged latent infection. 
Both of the tertiary isolates displayed only single additional SNPs in relation to their 
respective putative predecessors (the two reactivated isolates), confirming their status 
as recent transmissions.  
Molecular clock rates. Due to the rather limited number of mutations observed in Links 
1 and 2 (Table S3), we performed a second round of variant calling on these four 
isolates, in which a more closely related Mtb strain, CTRI-2, was used as a reference 
(Figure 1c; Table 1). The four isolates displayed 97 common SNPs and 17 indels in 
relation to CTRI-2 (Table S4). We also used de novo assembled scaffolds to ensure the 
validity of all SNP-calls inside or in the proximity of known repetitive regions, which led 
to the identification of three additional SNPs. Link 1 showed the accumulation of eight 
SNPs and one indel over 33 years, while Link 2 (the father and the son) showed the 
accumulation of 10 SNPs during the same time-period. The two links (i.e. the two 
primary isolates) were themselves separated by five SNPs. Thus, we find an average 
molecular clock rate of 0.2 – 0.3 SNPs per genome per year. Interestingly, this compares 
quite well to rates of mutation acquisition observed previously in Lineage 4, both in 
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vitro (Ford et al., 2011; Ford et al., 2013) and in several independent retrospective 
outbreak studies (Eldholm et al., 2015; Guerra-Assuncao et al., 2015; Walker et al., 
2013). While current models of Mtb during latency assume that there is little or no 
growth or mutation of the infecting bacteria, a recent in vitro study using a macaque 
model has provided evidence that Mtb mutates at a fixed rate over time, and that 
mutation rates are comparable between latent and active disease (Ford et al., 2011). 
However, while these and other results (Ford et al., 2013) suggest that the mutation rate 
remains largely constant irrespective of disease state, it is important to emphasize that 
such observations have so far been characterized by small sample sizes. Furthermore, 
Colangeli et al (Colangeli et al., 2014) have provided contrasting evidence by showing 
mutation rates ten times lower during latency than active disease by examining four 
strains, two of them latent for more than 20 years, derived from the same index case. 
Mutational patterns and within-host selection The diversifying processes that 
contribute to mutation accumulation during long-term latent infection remain poorly 
understood. Such processes can be investigated by studying mutational patterns as 
revealed by genome sequencing. We first examined a previously proposed hypothesis 
that mutation accumulation during latency is often the product of oxidative damage 
(Ford et al., 2011). Links 1 and 2 were inspected for molecular signatures indicative of 
oxidative damage, either cytosine deamination (GC to AT changes) or formation of 8-
oxoguanine (GC to TA changes). For Link 2, 30% of observed SNPs were GC>AT or 
GC>TA mutations, highly comparable to the 36% observed in the CTRI-2 background. 
Despite Link 1 having a notably higher proportion of these mutations (75%), it was not 
quite statistically significant (Fisher’s exact test, P = 0.054) due to the low number of 
observed polymorphisms. We therefore found no real evidence supporting that 
oxidative stress is the dominant contributing factor during latent infection in our data. A 
similar observation was also made by Colangeli et al (Colangeli et al., 2014).  
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We also investigated the role of within-host evolution during latent infection by 
comparing synonymous and non-synonymous polymorphisms in the two only 
confirmed re-activated isolates as well as the number of putatively deleterious 
mutations. A previous study revealed significantly reduced levels of purifying selection 
(average pairwise dN/dS = 0.57) throughout the Mycobacterium tuberculosis complex 
(MTBC) with typically 40% of amino acid changes having functional consequences 
(Hershberg et al., 2008). A similar ratio (0.53) was also observed prior to a major Mtb 
outreak (pre-diversification) among Inuit in the Nunavik region of Canada, while 
significantly elevated ratios (0.95 and 0.76, respectively) were observed during the 
outbreak in two separate sub-lineages (post-diversification)(Lee et al., 2015). Thus, the 
ratio observed in the CTRI-2 background and Link 1 (dN/dS = 0.56) corresponds well 
with Nunavik pre-diversification rates and those observed overall throughout the MTBC. 
Interestingly, we found a significant overrepresentation of both non-synonymous SNPs 
(dN/dS = 2.5; Poisson, P = 0.0011) and putatively deleterious mutations (86%; Fisher’s 
exact test; P = 0.0032) in Link 2, demonstrating a clear divergence from the CTRI-2 
background. The underlying cause of this variation in the mutational pattern is 
unknown, and could merely reflect random genetic drift combined with serial 
bottlenecking owing to low effective population sizes. Such factors are influenced by 
distinct environmental conditions at different sites of infection or lesion types in the 
infected individual. Analysis of multiple isolates from latent infections is therefore 
required to fully understand the role of the different mutational processes and selective 
forces acting on the latent bacteria.  
Gene selection. We did not observe mutations in any of the secondary- or tertiary 
isolates that could be linked to established drug resistance phenotypes. We note, 
however, that genes Rv3805c (aftB) and Rv3130c (tgs1), which both contained putative 
deleterious mutations in isolate R98-3208 (Link 2), have been previously implicated in 
processes that may influence the development of antibiotic resistance and tolerance 
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(Daniel et al., 2004; Safi et al., 2013). However, the putatively deleterious tgs1 mutation 
in R98-3208 is particularly intriguing in a purely metabolic context as it is essential for 
accumulation of triacylglycerol (TAG) in response to hypoxia and other stresses (Daniel 
et al., 2004). Furthermore, TAG-synthesis plays a direct role in promoting entry into a 
dormancy-like state (Daniel et al., 2004). Increased expression of tgs1, observed in 
certain Beijing lineages of Mtb, is speculated to offer increased survival within host 
tissues as a consequence of high TAG-levels (Reed et al., 2007). 
Concluding remarks 
Overall, our study underpins the challenges associated with identification of relevant 
bacterial isolates, and highlights the importance of systematic sampling and whole 
genome sequencing of Mtb in relation to refining our understanding of underlying 
mechanisms of long-term persistence in the host. While these and other observations 
contribute to our understanding of the bacterial in vivo lifecycle it remains to be seen if 
and how these findings scale over prolonged latent TB infections in humans. The rate of 
molecular evolution observed here in combination with the finding that mutations with 
relevance for the physiological state of the infecting bacteria may emerge during latency, 
emphasize the importance of identifying and controlling cases of latent infections.  
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Figure legends 
 
Fig. 1 A proposed timeline (a) of routes of transmission (dotted arrows) between Mtb 
isolates from 14 TB patients based on existing IS6110-RFLP typing. Each line begins at 
birth and ends with the onset of active TB (filled circles) followed by the patients’ age (in 
years) at the time. Lighter areas represent periods in which the patient is assumed to 
have been uninfected, while darkly colored areas is the assumed period of (latent) TB. A 
Maximum-likelihood analysis (b) based on 9,401 single-nucleotide polymorphisms 
(SNPs) showed that all belong to the Euro-American Mtb lineage (Lineage 4). Sublineage 
assignments are based on presence of established informative SNPs and lineage-
defining regions of difference (RDs). A maximum-parsimony analysis (c) of the four M. 
tuberculosis clones from Links 1 & 2, based on SNPs relative to Mtb CTRI-2 (Lineage 
4.3.3 reference). Individual branches are labeled in roman numerals, followed by the 
number of SNPs on that branch in brackets. Year of isolation are indicated in brackets at 
each branch tip. 
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Table 1. Single nucleotide polymorphisms (SNPs) of Mtb isolates from Links 1 & 2 called using Mtb CTRI-2 as the reference genome.   
 
 
Position Variant Gene SNP Frequencies
a
 ORF NT 
change 
Synonymous 
SNP 
AA 
Change
b
 
Annotation
c
 
Mu837 R94-2977 Mu838 R94-3208 
Branch I
d
 
3,902,730 G->A mce4F 
(MTCTRI2_3560) 
0.02 (61) 0.00 (106) 0.98 (63) 1.00 (37) C1530T N P510L MCE-family protein MCE4F 
Branch II 
250,770 C->T MTCTRI2_0214 0.00 (117) 0.00 (136) 0.00 (119) 1.00 (109) C895T N Q299* Hypothetical protein 
842,514 A->T . 0.00 (138) 0.00 (192) 0.00 (102) 1.00 (136) . . . Intergenic region 
(MTCTRI2_0766/MTCTRI2_
0767) 
1,102,021 T->C . 0.00 (133) 0.00 (188) 0.00 (129) 0.99 (129) . . . Intergenic region 
(mscL/MTCTRI2_1010) 
1,291,604 G->C narH 
(MTCTRI2_1194) 
0.00 (146) 0.00 (187) 0.00 (116) 1.00 (116) G177C N Q59H Respiratory nitrate reductase 
subunit beta NarH 
1,569,291 T->C cyp132 
(MTCTRI2_1431) 
0.00 (128) 0.00 (148) 0.00 (125) 1.00 (119) A621G N Y207C Cytochrome P450 132 
2,461,641 G->A ctaC 
(MTCTRI2_2235) 
0.00 (122) 0.00 (192) 0.00 (81) 1.00 (90) C188T N P63S Transmembrane cytochrome C 
oxidase subunit II CtaC 
3,492,216 A->G tgs1 
(MTCTRI2_3193) 
0.00 (137) 0.00 (243) 0.00 (122) 0.99 (137) T1296C N L432P Triacylglycerol synthase 
4,046,395 C->G ppe65 
(MTCTRI2_3686) 
0.00 (117) 0.00 (186) 0.00 (117) 1.00 (93) G1072C Y . PPE family protein 
4,182,139 G->A ctpJ 
(MTCTRI2_3816) 
0.00 (116) 0.00 (152) 0.00 (127) 1.00 (104) C225T N A75V Cation transporter P-type 
ATPase CtpJ 
4,255,227 A->G aftB 
(MTCTRI2_3884) 
0.00 (108) 0.00 (164) 0.00 (137) 1.00 (127) T600C N M200T Possible 
arabinofuranosyltransferase 
AftB 
Branch III 
1,862,175 T->A argR 
(MTCTRI2_1686) 
1.00 (117) 1.00 (164) 0.00 (119) 0.00 (96) T83A N I28N Arginine repressor 
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1,862,176 C->T argR 
(MTCTRI2_1686) 
1.00 (116) 1.00 (163) 0.00 (118) 0.00 (97) C84T N . Arginine repressor 
2,337,938 G->A . 1.00 (37) 1.00 (63) 0.00 (32) 0.00 (36) . . . Intergenic region 
(lppJ/MTCTRI2_2120) 
2,337,943 G->A . 1.00 (35) 1.00 (62) 0.00 (27) 0.00 (33) . . . Intergenic region 
(lppJ/MTCTRI2_2120) 
2,837,047 G->A fas 
(MTCTRI2_2572) 
0.99 (86) 1.00 (130) 0.02 (63) 0.00 (77) C7191T N S2397L Fatty acid synthase 
Branch IV 
1,274,252 C->A mmpL13b 
(MTCTRI2_1178) 
1.00 (121) 0.00 (158) 0.00 (110) 0.00 (119) C536A N A179E Transmembrane transport 
protein MmpL13B 
Branch V 
404,025 C->A MTCTRI2_0343 0.00 (99) 1.00 (153) 0.00 (92) 0.00 (81) C1487A N P496H 13E12 repeat family protein 
534,952 G->A ufaA1 
(MTCTRI2_0450) 
0.00 (121) 1.00 (179) 0.00 (132) 0.00 (133) C1277T N P426S Cyclopropane-fatty-acyl-
phospholipid synthase 
534,953 G->A ufaA1 
(MTCTRI2_0450) 
0.00 (121) 1.00 (172) 0.00 (129) 0.00 (134) C1276T Y . Cyclopropane-fatty-acyl-
phospholipid synthase 
2,432,547 G->A idsA2 
(MTCTRI2_2208) 
0.00 (110) 1.00 (177) 0.00 (118) 0.00 (140) G568A N V190I Geranylgeranyl pyrophosphate 
synthetase 
2,751,892 G->A MTCTRI2_2500 0.00 (126) 1.00 (207) 0.00 (127) 0.00 (133) C1124T Y . Oxidoreductase alpha subunit 
3,116,605 C->G MTCTRI2_2870 0.00 (79) 0.98 (112) 0.00 (78) 0.00 (3) G284C N A95P Transposase 
3,669,145 >C< pcd 
(MTCTRI2_3360) 
0.00 (142) 1.00 (197) 0.00 (159) 0.00 (135) . . . Piperideine-6-carboxylic acid 
dehydrogenase 
4,271,165 C->G MTCTRI2_3898 0.00 (151) 1.00 (236) 0.00 (139) 0.00 (176) C181G N R61G Hypothetical protein 
4,361,068 C->T esxD 
(MTCTRI2_3970) 
0.00 (155) 0.99 (159) 0.00 (119) 0.00 (131) G295A Y . ESAT-6 like protein EsxD 
a SNP frequencies are followed by mapping depth in parenthesis. Alleles with a frequency above 0.85 were considered fixated (bold).  
b Amino acid changes marked in bold are putatively deleterious based on Provean analysis.    
c Gene annotations marked in bold are normally filtered out in Mtb variant analysis but were validated by visual inspection of mapped reads in this study. 
d Branch numbers refer to branches in Fig. 1c 
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